To confirm that the responsiveness of pituitary adenoma cells to In1-ghrelin peptides was translated into further functional outcomes, in vitro hormone secretion was assessed in a subset of tumors in response to In1-ghrelin peptides, and, when cells were available, also to AG. Here, GHRL is linked to pituitary gland adenoma.